140 related articles for article (PubMed ID: 36752319)
21. Identification of inhibitor binding hotspots in Acinetobacter baumannii β-ketoacyl acyl carrier protein synthase III using molecular dynamics simulation.
Ha Y; Jang M; Lee S; Lee JY; Lee WC; Bae S; Kang J; Han M; Kim Y
J Mol Graph Model; 2020 Nov; 100():107669. PubMed ID: 32659632
[TBL] [Abstract][Full Text] [Related]
22. Determination of potential combination of non-β-lactam, β-lactam, and β-lactamase inhibitors/β-lactam enhancer against class D oxacillinases producing Acinetobacter baumannii: Evidence from in-vitro, molecular docking and dynamics simulation.
Gopikrishnan M; Ramireddy S; Varghese RP; Bakathavatchalam YD; D TK; Manesh A; Walia K; Veeraraghavan B; C GPD
J Cell Biochem; 2023 Jul; 124(7):974-988. PubMed ID: 37282600
[TBL] [Abstract][Full Text] [Related]
23. Molecular docking and dynamic approach to screen the drug candidate against the Imipenem-resistant CarO porin in Acinetobacter baumannii.
Gopikrishnan M; George Priya Doss C
Microb Pathog; 2023 Apr; 177():106049. PubMed ID: 36858184
[TBL] [Abstract][Full Text] [Related]
24. Moleculer dynamics simulaiton revealed reciever domain of
Ahmad S; Shaker B; Ahmad F; Raza S; Azam SS
J Biomol Struct Dyn; 2019 Jul; 37(11):2897-2912. PubMed ID: 30043709
[No Abstract] [Full Text] [Related]
25. Structure prediction and discovery of inhibitors against phosphopantothenoyl cysteine synthetase of
Gupta A; Vijayan V; Pant P; Kaur P; Singh TP; Sharma P; Sharma S
J Biomol Struct Dyn; 2022; 40(21):11405-11417. PubMed ID: 34348086
[No Abstract] [Full Text] [Related]
26. Integrated computer-aided drug design and biophysical simulation approaches to determine natural anti-bacterial compounds for Acinetobacter baumannii.
Almihyawi RAH; Naman ZT; Al-Hasani HMH; Muhseen ZT; Zhang S; Chen G
Sci Rep; 2022 Apr; 12(1):6590. PubMed ID: 35449379
[TBL] [Abstract][Full Text] [Related]
27. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
28.
Kumar A; Singh P; Singh E; Jain M; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2024 Mar; ():1-15. PubMed ID: 38486459
[TBL] [Abstract][Full Text] [Related]
29. Characterization and Inhibition of 1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase: A Promising Drug Target in
Ball HS; Girma MB; Zainab M; Soojhawon I; Couch RD; Noble SM
ACS Infect Dis; 2021 Nov; 7(11):2987-2998. PubMed ID: 34672535
[TBL] [Abstract][Full Text] [Related]
30. Identification and prioritization of potential therapeutic molecules against LpxA from
Khan RJ; Singh E; Jha RK; Kumar A; Bhati SK; Zia MP; Jain M; Singh RP; Muthukumaran J; Singh AK
Curr Res Struct Biol; 2023; 5():100096. PubMed ID: 36895415
[TBL] [Abstract][Full Text] [Related]
31. C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major
Stewart NK; Toth M; Alqurafi MA; Chai W; Nguyen TQ; Quan P; Lee M; Buynak JD; Smith CA; Vakulenko SB
mBio; 2022 Jun; 13(3):e0036722. PubMed ID: 35420470
[TBL] [Abstract][Full Text] [Related]
32. Computational identification of candidate inhibitors for Dihydrofolate reductase in
Bhati SK; Jain M; Muthukumaran J; Singh AK
Curr Res Struct Biol; 2024; 7():100127. PubMed ID: 38322649
[No Abstract] [Full Text] [Related]
33. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
Singh VK; Ghosh I
FEBS Lett; 2013 Sep; 587(17):2806-17. PubMed ID: 23816706
[TBL] [Abstract][Full Text] [Related]
34. Structure-based identification of novel inhibitors targeting the enoyl-ACP reductase enzyme of Acinetobacter baumannii.
Khan S; Madhi SA; Olwagen C
Sci Rep; 2023 Dec; 13(1):21331. PubMed ID: 38044353
[TBL] [Abstract][Full Text] [Related]
35. Structure-based identification of potential natural compound inhibitors targeting bacterial cytoskeleton protein FtsZ from
Roy Chowdhury S; Saha R; Koley T; Naz F; Sharma S; Khan MI; Kumar M; Kaur P; Ethayathulla AS
J Biomol Struct Dyn; 2024 Jan; ():1-13. PubMed ID: 38239064
[No Abstract] [Full Text] [Related]
36. Comparative subtractive proteomics based ranking for antibiotic targets against the dirtiest superbug: Acinetobacter baumannii.
Ahmad S; Raza S; Uddin R; Azam SS
J Mol Graph Model; 2018 Jun; 82():74-92. PubMed ID: 29705560
[TBL] [Abstract][Full Text] [Related]
37. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
[TBL] [Abstract][Full Text] [Related]
38. Molecular docking, dynamics and free energy analyses of
Ramachandran B; Jeyakanthan J; Lopes BS
J Med Microbiol; 2020 Aug; 69(8):1062-1078. PubMed ID: 32773005
[No Abstract] [Full Text] [Related]
39. Structure-based virtual screening and molecular dynamics simulations for detecting novel candidates for allosteric inhibition of EGFRT790M.
Çoban G
J Biomol Struct Dyn; 2024; 42(2):571-597. PubMed ID: 37029759
[TBL] [Abstract][Full Text] [Related]
40. Discovery of multi-target mur enzymes inhibitors with anti-mycobacterial activity through a Scaffold approach.
Kumari M; Waseem M; Subbarao N
J Biomol Struct Dyn; 2023 Apr; 41(7):2878-2899. PubMed ID: 35174764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
